Stereotaxis Makes A Strategic Acquisition Bolstering Its Future (NYSE:STXS)


Young doctors stitching the puzzle

gehringj/E+ via Getty Images

Stereotaxis Reports Solid Results

We must contextualize Stereotaxis’ (NYSE:STXS) reported results until their new products get approved. The company will have limited sales growth and a modest cash burn in the meantime. This doesn’t mean we

Leave a Reply

Your email address will not be published. Required fields are marked *